Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Kraig Biocraft Laboratories (KBLB) Change in Accured Expenses (2016 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Change in Accured Expenses for 11 consecutive years, with $187709.0 as the latest value for Q4 2022.

  • Quarterly Change in Accured Expenses rose 18.58% to $187709.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $470448.0 through Dec 2022, up 6.54% year-over-year, with the annual reading at $947747.0 for FY2025, 15.79% up from the prior year.
  • Change in Accured Expenses hit $187709.0 in Q4 2022 for Kraig Biocraft Laboratories, up from $100033.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $228631.0 in Q4 2018 to a low of $189.0 in Q2 2021.
  • Historically, Change in Accured Expenses has averaged $135209.5 across 4 years, with a median of $150360.0 in 2018.
  • Biggest YoY gain for Change in Accured Expenses was 37386.24% in 2022; the steepest drop was 50.17% in 2022.
  • Year by year, Change in Accured Expenses stood at $228631.0 in 2018, then decreased by 28.83% to $162725.0 in 2019, then fell by 2.72% to $158301.0 in 2021, then grew by 18.58% to $187709.0 in 2022.
  • Business Quant data shows Change in Accured Expenses for KBLB at $187709.0 in Q4 2022, $100033.0 in Q3 2022, and $70849.0 in Q2 2022.